《基立福Grifols 2023年综合及可持续发展年度报告-摘要「NYSE」（英文版）（56页）.pdf》由会员分享，可在线阅读，更多相关《基立福Grifols 2023年综合及可持续发展年度报告-摘要「NYSE」（英文版）（56页）.pdf（56页珍藏版）》请在三个皮匠报告上搜索。

1、2023 EXECUTIVE SUMMARY:INTEGRATED AND SUSTAINABILITY ANNUAL REPORT 2023 EXECUTIVE SUMMARY:INTEGRATED AND SUSTAINABILITY ANNUAL REPORT22023 Executive Summary:Integrated and Sustainability Annual Report 202332023 Executive Summary:Integrated and Sustainability Annual Report 2023This report is an execu

2、tive summary of the Integrated and Sustainability Annual Report,which is available for consultation through this link.In it,you will find relevant information about our management,financial results,and sustainability.IndexBlock 1:Understanding GrifolsWe are Grifols.4Our global footprint .6Our busine

3、ss model generates value.8Sustainability and human rights .10Grifols value chain .14Donors and patients .18Innovation at Grifols .22Block 2:Grifols ESGEnvironment .26Social.32Governance .40Block 3:Sustainable growth Financial performance.48Value creation beyond economic profit .52Taxation.5342446420

4、23 Executive Summary:Integrated and Sustainability Annual Report 2023Block 1:Understanding GrifolsWe are GrifolsGrifols has aspired to promote innovation and plasma science since 1909,with a focus on social progress,responsible and sustainable business operations around the world,and adherence to a

5、legacy of solid values and ethical principles.OUR BUSINESS UNITSPlasma Procurement and BiopharmaPlasma procurement,production and commercialization of plasma-based and non-plasma-based treatments85%over revenueDiagnosticLeading-edge diagnostic solutions to analyze blood and plasma10%over revenueBio

6、SuppliesBiological products for non-therapeutic use2%over revenueOthersSpecialty pharmaceuticals and hospital management solutions 3%over revenueBiotestEmployees:2,300+Plasma centers:33+Projects at advanced development stages:2 WITH BIOTEST,WE IMPROVE THE LIVES OF THOUSANDS OF PEOPLEImmunology Immun